Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Soleno Therapeutics (SLNO) Other Gross PP&E Adjustments (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with -$13.5 million as the latest value for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments changed N/A year-over-year to -$13.5 million; the TTM value through Dec 2025 reached -$13.5 million, changed N/A, while the annual FY2025 figure was -$13.5 million, N/A changed from the prior year.
  • Other Gross PP&E Adjustments hit -$13.5 million in Q4 2025 for Soleno Therapeutics, down from -$5.8 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$2.4 million in Q2 2025 and bottomed at -$13.5 million in Q4 2025.